Clinical Data Buys Epidauros for $11.8M Cash to Upgrade PGx Play | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data today said it has acquired privately held Epidauros Biotechnologie for €8.7 million ($11.8 million) in cash to help flesh out its pharmacogenomics abilities.
Clinical Data said it bought Epidauros for its portfolio of genetic biomarkers, expertise in genetic biomarker discovery, relationships with “leading” diagnostic companies, and its “fast-growing” pharmacogenomics services business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.